Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have ...

A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 ...

In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.

The new oral medication, daraxonrasib, has been shown to meaningfully extend the lives of patients with late-stage pancreatic ...

Scientists long ago identified their target: a smooth-surfaced protein inside cells, called KRAS, that is altered in certain ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...

Patients — and their doctors — have been desperate for a more effective pancreatic cancer treatment for decades. Now one ...

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...

It is poised to revolutionize cancer treatment. An experimental drug that targets pancreatic cancer is being fast tracked for ...

Our fraught national debate over immunization and public health has overshadowed some extremely encouraging advances being made by researchers in the decades-long battle against cancer. Recent news of ...

Pancreatic cancer is mostly pancreatic ductal adenocarcinoma, with late-stage detection due to non-specific symptoms like jaundice and abdominal pain. Diagnosis involves imaging tests, biopsies, and ...